Microbial spectrum evolution and antibiotic resistance in urinary tract infections
Închide
Articolul precedent
Articolul urmator
55 0
SM ISO690:2012
OPREA, Andrei, DRUTA, Daniela, SYNYTSINA, Yuliia, MÎȚU, Alexandru, PASCAL, Rodica, GUTU, Biatricia, FOLTEA, Luminita, TĂNASE, Adrian. Microbial spectrum evolution and antibiotic resistance in urinary tract infections. In: New horizons in urology: The 8th congress on urology, dialysis and kidney transplant from Republic of Moldova with international participation, 7-9 iunie 2023, Chişinău. Chişinău: Taicom (Ridgeone Group), 2023, p. 365. ISSN 2558-815X.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
New horizons in urology 2023
Conferința "New horizons in urology"
Chişinău, Moldova, 7-9 iunie 2023

Microbial spectrum evolution and antibiotic resistance in urinary tract infections


Pag. 365-365

Oprea Andrei1, Druta Daniela1, Synytsina Yuliia2, Mîțu Alexandru12, Pascal Rodica12, Gutu Biatricia12, Foltea Luminita1, Tănase Adrian1
 
1 ”Nicolae Testemițanu” State University of Medicine and Pharmacy,
2 Timofei Moșneaga Republican Clinical Hospital
 
 
Disponibil în IBN: 27 martie 2024


Rezumat

Introduction. Antimicrobial resistance is a global public health problem that can lead to treatment failure, increased mortality and morbidity associated with urinary tract infections. Objective. To evaluate the results of urine cultures collected at T. Mosneaga Clinical Hospital, with a focus on identifying the evolution of microbial spectrum and antibiotic resistance. Material and methods. A retrospective study was conducted involving analysis of urine culture results collected from hospitalized patients between 2018-2021. A total of 22,076 urine cultures were included. Urine cultures were collected within the first 48 hours of hospitalization. Results. Out of the total of 22,076 urine samples, 5,500 were positive for pathogens (24.9%). Gram-negative microorganisms (Enterobacteriaceae - 60%) were the most commonly identified, with a decreasing incidence over the years, followed by Klebsiella pneumonia (20%) and Pseudomonas aeruginosa (10%), the latter showing an increasing incidence. Sensitivity was higher (85%) for antibiotics from the aminoglycoside group (amikacin), while preparations from the fluoroquinolone group (ciprofloxacin) showed lower sensitivity (37%). Conclusion. It has been demonstrated that over the reference years, the evolution of the microbial spectrum was characterized by an increasing incidence of Klebsiella P. and Pseudomonas A., with a corresponding decrease in the incidence of Enterobacteriaceae. The identified agents showed increased sensitivity to aminoglycosides and significant antibacterial resistance to fluoroquinolones. The most spectacular evolution was recorded during the Covid-19 pandemic (2019-2020).